U.S. market Closed. Opens in 30 minutes

INCR | InterCure Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue355.55M388.68M219.68M65.03M8.93MN/AN/A
Cost of Revenue250.46M233.60M128.55M33.06M7.45MN/AN/A
Gross Profit105.09M155.08M91.13M31.98M1.48MN/AN/A
Operating Expenses67.50M102.15M58.10M28.62M81.61M9.81M1.12M
Selling, General & Admin86.24M97.32M53.94M26.30M79.05M9.81M1.12M
Research & Development388.00K632.00K1.24M1.58M1.71MN/AN/A
Other Operating Expenses-7.41M4.20M2.93M745.00K853.00KN/AN/A
Operating Income-41.57M52.80M28.19M-1.45M-80.14M-10.62M-3.98M
Other Expenses / Income-77.88M-8.96M-9.45M-36.86M76.47M-1.95M-1.28M
Before Tax Income-61.28M43.84M18.74M-38.31M-3.67M-12.80M-5.26M
Income Tax Expenses2.25M93.00K11.44M-2.27M-673.00K-1.15MN/A
Net Income-61.96M44.82M7.30M-36.04M-3.00M-12.80M-5.26M
Interest Expenses24.22M14.69M5.04M264.00K1.84M1.03M639.51K
Basic Shares Outstanding45.56M45.35M46.92M25.40M23.30M20.60M16.78M
Diluted Shares Outstanding45.56M45.35M46.92M25.40M23.30M20.60M17.11M
EBITDA46.57M64.50M37.58M1.80M-21.20M-8.16M-4.62M
EBITDA Margin13.10%16.59%17.11%2.78%-237.55%0.00%0.00%
EBIT-35.49M59.60M23.78M-38.04M-1.83M-12.92M-4.62M
EBIT Margin-9.98%15.33%10.83%-58.50%-20.51%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙